Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
B
Bachmann, Laura
Centers for Disease Control/DSTDP
STI guidelines
Location: Sheraton Ballroom
Laura Bachmann
SY9.4 - Strategies to prevent congenital syphilis
Location: Sheraton 2
Laura Bachmann
Bacon, Oliver
San Francisco City Clinic, San Francisco Department of Public Health
O6.1 - High uptake of Doxycycline for STI prevention (doxy-PEP) among individuals using HIV PrEP at a municipal sexual health clinic in San Francisco, California
Location: Chicago 10
Oliver Bacon
Baptiste, Solange
International Treatment Preparedness Coalition (ITPC)
SY4.2 - Community-Led Responses: Vital for Effective STI Interventions, Policy and Impact
Location: Chicago 7
Solange Baptiste
Barbee, Lindley
University of Washington
O13 - 2022 Mpox outbreak: Challenges and Innovations
Location: Michigan A/B
Lindley Barbee
SY2.3 - Future treatments for STIs
Location: Chicago 7
Lindley Barbee
Barclay, Lynn
Plenary 2: Sexual Health and Sexual Pleasure
Location: Sheraton Ballroom
Lynn Barclay
Batteiger, Teresa
Indiana University School of Medicine
Optimizing urethritis treatment – M. genitalium and pathogens of idiopathic urethritis
Location: Chicago 8
Teresa Batteiger
Beale, Mathew
Wellcome Sanger Institute
O3.4 - Evolutionary insights into syphilis epidemiology - applying Treponema pallidum genomics in high- and low-income settings
Location: Chicago 10
Mathew Beale
Bebear, Cecile
Bordeaux University Hospital
LB1.1 - Prevalence and epidemiology of Lymphogranuloma venereum in France, 2020-2022
Location: Michigan A+B
Cecile Bebear
Benzaken, Adele
University of Brasília / Oswaldo Cruz Foundation (Instituto Leonidas & Maria Deane)
Tackling stigma, strengthening communities
Location: Chicago 6
Adele Benzaken
Birkmann, Alexander
AiCuris Anti-Infective Cures AG
O5.5 - Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program
Location: Chicago 9
Alexander Birkmann
Blair, Cherie S
Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA
O2.5 - Mixed methods analysis of network structures, support exchanged, and communication patterns within the social networks of transgender women in Lima, Peru
Location: Chicago 10
Cherie S Blair
Bond, Keosha
CUNY School of Medicine
PL2.1 - Putting pleasure back into sexual health - 1
Location: Sheraton Ballroom
Keosha Bond
Borges, Alvaro
Centre for Vaccine Research, Statens Serum Institut
SY3.3 - State of chlamydia vaccine development
Location: Chicago 6
Alvaro Borges
Bradshaw, Catriona
Monash University and Melbourne Sexual Health Centre
SY2.2 - Molecular resistance prediction and resistance-guided STI therapy - when and how to use
Location: Chicago 7
Catriona Bradshaw
SY5.2 - Male Partner Treatment for Women with Bacterial Vaginosis
Location: Chicago 6
Catriona Bradshaw
Broad, Claire
St George's, University of London
O4.3 - MgSeq: Enabling M. genitalium identification and antimicrobial resistance detection in genital and extra-genital samples from female sex workers in Ecuador using multiplex PCR and nanopore sequencing
Location: Chicago 8
Claire Broad
Brown, Sarah
University of Maryland School of Medicine
O1.1 - Bacterial Vaginosis and Spontaneous Clearance of Urogenital Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora
Location: Chicago 8
Sarah Brown
Bunjun, Rubina
Institute of Infectious Disease and Molecular Medicine, University of Cape Town
O15.4 - Characterising CD4+ T cell responses to Chlamydia trachomatis in highly exposed young South African women
Location: Sheraton 1
Rubina Bunjun
Burnstein, Kyle
Epidemic preparedness: Mpox and beyond
Location: Sheraton Ballroom
Kyle Burnstein
